| 國立成功大學 |
2023 |
Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which Patients Are Suited for Additional Adjuvant Chemoradiation Therapy: From a Prospective Randomized
|
Chiu, Y.-F.;Liu, T.-W.;Shan, Y.-S.;Chen, J.-S.;Li, C.-P.;Ho, C.-L.;Hsieh, R.-K.;Hwang, T.-L.;Chen, L.-T.;Ch'ang, H.-J. |
| 臺大學術典藏 |
2022-08-19T00:21:12Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; CHIUN HSU; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2022-08-19T00:21:09Z |
Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: A preliminary result
|
Liang P.-C.; Ch'ang H.-J.; CHIUN HSU; Tseng S.S.; Shih T.T.F.; Wu Liu T. |
| 臺大學術典藏 |
2022-02-23T02:12:30Z |
Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma
|
Ch'Ang H.-J.; Hsu C.; CHIEN-HUNG CHEN; Chang Y.-H.; Chang J.S.; Chen L.-T. |
| 臺大學術典藏 |
2022-02-22T05:34:22Z |
Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma
|
Ch'Ang H.-J.; Hsu C.; CHIEN-HUNG CHEN; Chang Y.-H.; Chang J.S.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T02:02:13Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; ANN-LII CHENG; Hsu C.; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:18Z |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang H.-J.; Huang C.-L.; Wang H.-P.; Shiah H.-S.; Chang M.-C.; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; ANN-LII CHENG; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:05Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-08-31T06:29:42Z |
A phase i clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment John T Kung
|
Liu K.-J.; Chao T.-Y.; Chang J.-Y.; ANN-LII CHENG; Ch'Ang H.-J.; Kao W.-Y.; Wu Y.-C.; Yu W.-L.; Chung T.-R.; Whang-Peng J. |
| 臺大學術典藏 |
2021-05-26T09:08:35Z |
Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia
|
Ch'ang H.-J.; Tien H.-F.; Wang C.-H.; Chuang S.-M.; YAO-CHANG CHEN; Shen M.-C.; Lin D.-T.; Lin K.-H. |
| 臺大學術典藏 |
2021-05-25T06:36:16Z |
Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia
|
Ch'ang H.-J.; Tien H.-F.; Wang C.-H.; Chuang S.-M.; Chen Y.C.; MING-CHING SHEN; Lin D.-T.; Lin K.-H. |
| 臺大學術典藏 |
2021-03-05T06:07:34Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; Hsu C.; Lu Y.-S.; MING-CHU CHANG; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-03-05T06:07:26Z |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang H.-J.; Huang C.-L.; Wang H.-P.; Shiah H.-S.; MING-CHU CHANG; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; Cheng A.-L.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-03-05T06:07:25Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; MING-CHU CHANG; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-01-15T03:47:43Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; Hsu C.; Lu Y.-S.; Chang M.-C.; Lin J.-T.; HSIU-PO WANG; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-01-15T03:47:10Z |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang H.-J.; Huang C.-L.; HSIU-PO WANG; Shiah H.-S.; Chang M.-C.; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; Cheng A.-L.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-01-15T03:47:00Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; HSIU-PO WANG; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 國立成功大學 |
2021 |
High expression of kr�ppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
|
Pen, S.-L.;Shan, Y.-S.;Hsiao, C.-F.;Liu, T.-W.;Chen, J.-S.;Ho, C.-L.;Chou, W.-C.;Hsieh, R.-K.;Chen, L.-T.;Ch'ang, H.-J. |
| 臺大學術典藏 |
2020-08-11T08:36:58Z |
Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: A preliminary result
|
PO-CHIN LIANG; Ch'ang H.-J.; Hsu C.; Tseng S.S.; Shih T.T.F.; Wu Liu T. |
| 臺大學術典藏 |
2020-05-25T06:52:08Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'Ang H.-J;Wang C.-C;Cheng A.-L;Hsu C;Yen-Shen Lu;Chang M.-C;Lin J.-T;Wang H.-P;Shiah H.-S;Liu T.-W;Chang J.-Y;Whang-Peng J;Chen L.-T.; Ch'ang H.-J; Wang C.-C; Cheng A.-L; Hsu C; YEN-SHEN LU; Chang M.-C; Lin J.-T; Wang H.-P; Shiah H.-S; Liu T.-W; Chang J.-Y; Whang-Peng J; Chen L.-T. |
| 臺大學術典藏 |
2020-04-28T07:25:25Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; CHIH-HUNG HSU; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.; Ch'Ang H.-J. ;Lin Y.-L. ;Wang H.-P. ;Chiu Y.-F. ;Chang M.-C. ;Chih-Hung Hsu ;Tien Y.-W. ;Chen J.-S. ;Hsieh R.-K. ;Lin P.-W. ;Shan Y.-S. ;Cheng A.-L. ;Chang J.-Y. ;Whang-Peng J. ;Hwang T.-L. ;Chen L.-T. |
| 臺大學術典藏 |
2020-04-10T12:51:26Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'Ang H.-J.;Wang C.-C.;Cheng A.-L.;Chiun Hsu;Lu Y.-S.;Chang M.-C.;Lin J.-T.;Wang H.-P.;Shiah H.-S.;Liu T.-W.;Chang J.-Y.;Whang-Peng J.;Chen L.-T.; Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; Chiun Hsu; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2020-04-10T12:51:25Z |
Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: A preliminary result
|
Liang P.-C.;Ch'Ang H.-J.;Chiun Hsu;Tseng S.S.;Shih T.T.F.;Wu Liu T.; Liang P.-C.; Ch'ang H.-J.; Chiun Hsu; Tseng S.S.; Shih T.T.F.; Wu Liu T. |
| 臺大學術典藏 |
2020-04-10T12:51:15Z |
Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma
|
Ch'Ang H.-J.; Chiun Hsu; Chen C.-H.; Chang Y.-H.; Chang J.S.; Chen L.-T. |
| 臺大學術典藏 |
2020-03-07T06:48:18Z |
Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma
|
Ch'Ang H.-J.; Yu W.C.Y.; Tsai K.K.C.; Lin C.-Y.; Hsu C.-F.; Shan Y.-S.; Chu P.-Y.; Peng S.-L.; TSUI-LIEN MAO; Chang V.H.S. |
| 臺大學術典藏 |
2020-03-05T12:32:51Z |
Kr?ppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma
|
Chang V.H.S.; Chu P.-Y.; Peng S.-L.; TSUI-LIEN MAO; Shan Y.-S.; Hsu C.-F.; Lin C.-Y.; Tsai K.K.C.; Yu W.C.Y.; Ch'Ang H.-J. |
| 臺大學術典藏 |
2020-02-20T06:53:15Z |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang H.-J.; Shiah H.-S.; Chang M.-C.; Jan C.-M.; Chen J.-S.; YU-WEN TIEN; Hwang T.-L.; Lin J.-T.; Cheng A.-L.; Whang-Peng J.; Chen L.-T.; Wang H.-P.; Huang C.-L. |
| 臺大學術典藏 |
2020-02-20T06:53:13Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.; Shan Y.-S.; Cheng A.-L.; Lin P.-W.; Chen J.-S.; Hsieh R.-K.; YU-WEN TIEN; Ch'Ang H.-J.;Lin Y.-L.;Wang H.-P.;Chiu Y.-F.;Chang M.-C.;Hsu C.-H.;Yu-Wen Tien;Chen J.-S.;Hsieh R.-K.;Lin P.-W.;Shan Y.-S.;Cheng A.-L.;Chang J.-Y.;Whang-Peng J.;Hwang T.-L.;Chen L.-T.; Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2020-02-20T06:53:13Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.; Shan Y.-S.; Cheng A.-L.; Lin P.-W.; Chen J.-S.; Hsieh R.-K.; YU-WEN TIEN; Ch'Ang H.-J.;Lin Y.-L.;Wang H.-P.;Chiu Y.-F.;Chang M.-C.;Hsu C.-H.;Yu-Wen Tien;Chen J.-S.;Hsieh R.-K.;Lin P.-W.;Shan Y.-S.;Cheng A.-L.;Chang J.-Y.;Whang-Peng J.;Hwang T.-L.;Chen L.-T.; Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2018-09-10T04:38:07Z |
Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia
|
Ch'Ang, H.-J.;Tien, H.-F.;Wang, C.-H.;Chuang, S.-M.;Chen, Y.C.;Shen, M.-C.;Lin, D.-T.;Lin, K.-H.; KAI-HSIN LIN |
| 國立成功大學 |
2018 |
The role of consolidation chemoradiotherapy in locally advanced pancreatic cancer receiving chemotherapy: An updated systematic review and meta-analysis
|
Chang, J.S.;Chiu, Y.-F.;Yu, J.-C.;Chen, L.-T.;Ch'ang, H.-J. |
| 國立成功大學 |
2017 |
Kr�pple-like factor 10 regulates radio-sensitivity of pancreatic cancer via UV radiation resistance-associated gene
|
Chang, V.H.-S.;Tsai, Y.-C.;Tsai, Y.-L.;Peng, S.-L.;Chen, S.-L.;Chang, T.M.;Yu, W.C.-Y.;Ch'ang, H.-J. |
| 臺大學術典藏 |
2012 |
Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma
|
Chen C.-H.; Chang Y.-H.; Chang J.S.; Chen L.-T.; CHIUN HSU; Ch'Ang H.-J. |
| 臺大學術典藏 |
2007 |
Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: A preliminary result
|
Liang P.-C.; Ch'ang H.-J.; Hsu C.; Tseng S.S.; TIFFANY TING-FANG SHIH; Wu Liu T. |
| 臺大學術典藏 |
1993 |
Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia
|
Ch'ang H.-J.; HWEI-FANG TIEN; Wang C.-H.; Chuang S.-M.; Chen Y.C.; Shen M.-C.; Lin D.-T.; Lin K.-H. |
